Angelica Peebles
Pharma Reporter at CNBC
Pharma reporter at CNBC | Past: Biotech at Bloomberg | Formerly LaVito | Opinions my own
Articles
-
2 weeks ago |
cnbc.com | Angelica Peebles
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailCNBC's Angelica Peebles reports on news regarding vaccines.
-
4 weeks ago |
cnbc.com | Angelica Peebles
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailHHS cancels Moderna bird flu dealCNBC's Angelica Peebles joins 'Squawk Box' with the latest news.
-
1 month ago |
cnbc.com | Angelica Peebles
Residents of one of the states listed in the ‘Your Rights’ section of NBCUniversal’s Privacy Policy we have received your Global Privacy Control signal or you have opted out from the toggle below, but there is another step. To opt out of us selling or sharing/processing data such as your name, email address and other associated personal information for targeted advertising activities as described above, please submit the form below.
Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill
1 month ago |
cnbc.com | Angelica Peebles
Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pillEli Lilly chairman and CEO David Ricks joins 'Squawk Box' to discuss the company's quarterly earnings results, weight loss drug demand and competition, status of the company's weight loss drug pill, potential impact of tariffs, drug production outlook, and more.
-
1 month ago |
flipboard.com | Angelica Peebles
NowThe golf star is teaming up with the investment firm TPG on a new sports-related fund. Fresh off finally securing a career grand slam with a thrilling win at the Masters, Rory McIlroy, the world’s second-ranked golfer, is rounding out another corner of his life: investing. Mr. McIlroy’s investment …
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 8K
- DMs Open
- Yes
Previewing ASCO with J&J CEO Joaquin Duato https://t.co/RtQflrBJIH
RT @adamfeuerstein: $MRK Daiichi Sankyo withdraw FDA marketing application for patritumab deruxtecan (HER3-DxD) in EGFR-mutated non-small…
RT @AndrewE_Dunn: NEW: I dove into the precarious state of biotech's real-estate market Companies like Ginkgo, Prime, and Boundless Bio fa…